GLP-1, Ozempic
Ozempic maker Novo Nordisk has developed a pill that can cause weight loss of up to 13% in three months, according to new ...
A PILL from the makers of Ozempic and Wegovy leads to faster and longer-lasting weight loss than the popular ‘skinny jabs’, a ...
Ozempic maker Novo Nordisk (NVO) announced mixed results today for a phase 2 trial of an experimental weight loss pill that ...
Dr. Iris Gorfinkel joins us with the latest health headlines. From Health Canada’s approval of the new COVID vaccine and ...
An experimental weight-loss pill helped people drop 13% of their body weight in a three-month period. The results from early ...
Ozempic maker Novo Nordisk’s highly anticipated new obesity pill, Amycretin, shows the potential for much greater and faster ...
The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that delivered weight loss success by taking a daily pill.
Developed by Danish pharmaceutical giants Novo Nordisk behind Ozempic, the pill works by mimicking the action of two peptide hormones which regulate hunger and blood sugar levels, in one single ...
Also, Sen. Bernie Sanders spoke up again about Ozempic's manufacturer Novo Nordisk, alleging that it can make and sell its weight loss drug for under $100 a month. Meanwhile, CNN notes that GLP-1 ...